Augmented Reality Treadmill Training in Patients With Parkinson's Disease

Augmented Reality Treadmill Training in Patients With Parkinson's Disease: a Randomized Controlled Study

Status

Terminated

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04108741

Acronym

Falls_in_PD

Enrollment

Registered

2019-09-30

Start date

2020-09-15

Completion date

2025-06-10

Last updated

2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fall, Parkinson Disease

Keywords

Parkinson Disease

Brief summary

Gait disorder is a disabling symptom in Parkinson's disease (PD) affecting all patients during the course. Three methods of treadmill training (TT) will be compared to assess additional augmented reality (AR), or additional dual task (DT). AR TT, DT TT, and TT alone applied over 3 weeks at each day will be compared for their impact on falls, walking, freezing and attention for 3 months in a double blinded randomized controlled trial during regular neurorehabilitation.

Interventions

DEVICEC-Mill augmented reality treadmill training

PD Patients will be randomized to treadmill training with augmented reality or to treadmill training with random number generation or to treadmill training for 3 weeks at 5 days a week for 30 minutes.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

35 Years to 99 Years

Healthy volunteers

Inclusion criteria

* Informed Consent as documented by signature * Parkinson´s disease without dementia and hallucination * at least one fall within the past 3 months or postural instability * Gait disorder * Hoehn and Yahr stages II-IV * able to perform the treadmill therapy during a study

Exclusion criteria

* Contraindications to treadmill therapy (e.g. hip fracture) * Dementia as defined by an Montreal cognitive assessment (MOCA) \< 20

Design outcomes

Primary

Measure	Time frame	Description
Frequency of falls	3 months before study to 3 months following the study	group difference of the difference in falls

Secondary

Measure	Time frame	Description
Secondary outcomes:	before and after the training period of 3 weeks	Freezing of Gait (FOG) Questionnaire
Sensor based gait analyses	before and after the training period of 3 weeks and after 3 months	for one week

Countries

Switzerland

Contacts

PRINCIPAL_INVESTIGATORVeit Mylius, Prof. Dr.

Department of Neurology, Kliniken Valens

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 11, 2026